23 results
8-K/A
EX-3.1
THER
Theralink Technologies, Inc.
11 Jul 22
Amendments to Articles of Incorporation or Bylaws
7:29pm
8-K
EX-3.1
THER
Theralink Technologies, Inc.
7 Jul 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
10-K
2021 FY
EX-3.1
THER
Theralink Technologies, Inc.
Annual report
13 Jan 22
12:00am
8-K
EX-3.1
THER
Theralink Technologies, Inc.
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
10-Q
2020 Q3
EX-3.1
THER
Theralink Technologies, Inc.
Quarterly report
11 Jun 21
12:00am
8-K
EX-3.1
gx2p7 rkn
22 Sep 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.2
ir8yi0t 95t7jnqve
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.5
4py3caaaj5
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.1
f39yb3
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.3
8c3afmrcwb5ng3ky3i
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.4
yg9hj0e
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.1
vgoue5x0il9l34
13 Sep 19
Material Modifications to Rights of Security Holders
5:16pm
8-K
EX-3.1
rkxj 1sa700kqhh
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-3.1
vfl9a igc11m3
1 Nov 13
QUINT Engages Lexicon for Entertainment Public Relations
12:00am
8-K
EX-3.2
ko5lo9jb5wmk56cy
8 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.1
zt9j 9zln
8 Aug 13
Departure of Directors or Certain Officers
12:00am